Envista Holdings Corp. (NVST) Stock Analysis | Price, Returns, Financials & Key Metrics

Mojo Score Change: Envista Holdings Corp. has changed its score on 20 Nov 2025. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

612.98 k

Shareholding (Mar 2025)

FII

17.32%

Held by 177 FIIs

DII

5.75%

Held by 100 DIIs

Promoter

1.45%

How big is Envista Holdings Corp.?

22-Jun-2025

As of Jun 18, Envista Holdings Corp. has a market capitalization of 3,123.65 million, with net sales of 2,503.90 million and a net profit of -1,124.20 million over the latest four quarters. Shareholder's funds are 2,934.80 million, and total assets amount to 5,450.70 million.

What does Envista Holdings Corp. do?

22-Jun-2025

Envista Holdings Corporation is a small-cap dental products company in the Pharmaceuticals & Biotechnology industry, with net sales of $617 million and a market cap of approximately $3.12 billion as of March 2025. Key financial metrics include a P/E ratio of 73.00 and a return on equity of 1.44%.

Who are in the management team of Envista Holdings Corp.?

22-Jun-2025

As of March 2022, the management team of Envista Holdings Corp. includes Mr. Scott Huennekens (Independent Chairman), Mr. Amir Aghdaei (CEO), and several independent directors: Mr. Daniel Raskas, Ms. Wendy Carruthers, Mr. Kieran Gallahue, Mr. Vivek Jain, and Ms. Gayle Sheppard. This team provides governance and strategic direction for the company.

Is Envista Holdings Corp. overvalued or undervalued?

20-Sep-2025

As of August 7, 2025, Envista Holdings Corp. is considered undervalued with a favorable valuation grade shift, despite its recent stock performance lagging behind the S&P 500, showing a year-to-date return of 9.02% compared to the index's 12.22%.

Is Envista Holdings Corp. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, Envista Holdings Corp. has a mildly bullish technical trend, supported by positive MACD and Bollinger Bands, but caution is advised due to a mildly bearish OBV and underperformance compared to the S&P 500.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROCE of 6.67%

The company has been able to generate a Return on Capital Employed (avg) of 6.67% signifying low profitability per unit of total capital (equity and debt)

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 5.77

Poor long term growth as Net Sales has grown by an annual rate of 2.21% over the last 5 years

Negative results in Jun 25

With ROCE of 4.03%, it has a risky valuation with a 1.04 Enterprise value to Capital Employed

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 3,515 Million (Small Cap)

P/E

73.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.12

Return on Equity

2.07%

Price to Book

1.12

Revenue and Profits:

Net Sales:

682 Million

(Quarterly Results - Jun 2025)

Net Profit:

26 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-3.13%

6 Months

7.36%

1 Year

-2.14%

2 Years

-16.58%

3 Years

-42.19%

4 Years

-48.11%

5 Years

-37.77%

Envista Holdings Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Envista Holdings Corp. Experiences Evaluation Revision Amidst Mixed Financial Metrics

Envista Holdings Corp. has recently adjusted its valuation, with its stock price slightly increasing. Over the past year, the company has experienced a stock return of 7.05%, lagging behind the S&P 500. Key financial metrics reveal a mixed valuation landscape compared to industry peers, indicating diverse financial health within the sector.

Is Envista Holdings Corp. technically bullish or bearish?

As of 12 September 2025, the technical trend for Envista Holdings Corp. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating some positive momentum. The Bollinger Bands also reflect a bullish stance on the weekly and mildly bullish on the monthly. Daily moving averages are bullish, supporting the overall mildly bullish outlook. However, the OBV shows a mildly bearish trend on the monthly, which could signal some caution. In terms of performance, Envista has underperformed the S&P 500 over the past week and year, with returns of -2.68% and 9.65% respectively, compared to the S&P 500's returns of 1.05% and 17.14%. Overall, the current technical stance is mildly bullish, but the mixed signals suggest a need for careful monitoring....

Is Envista Holdings Corp. overvalued or undervalued?

As of 7 August 2025, the valuation grade for Envista Holdings Corp. has moved from expensive to attractive, indicating a shift towards a more favorable assessment. The company is currently considered undervalued, supported by a P/E ratio of 73, an EV to EBITDA of 13.83, and a Price to Book Value of 1.05. In comparison to peers, QIAGEN NV has a P/E of 24.20, while Masimo Corp. shows a significantly higher P/E of 179.74, reinforcing Envista's relative attractiveness. Despite the positive valuation outlook, Envista's recent stock performance has lagged behind the S&P 500, with a year-to-date return of 9.02% compared to the index's 12.22%. Over the past three years, the stock has declined by 38.69%, while the S&P 500 has gained 70.41%, highlighting the need for cautious optimism regarding its future performance....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

2.21%

EBIT Growth (5y)

9.80%

EBIT to Interest (avg)

5.77

Debt to EBITDA (avg)

1.35

Net Debt to Equity (avg)

0.12

Sales to Capital Employed (avg)

0.50

Tax Ratio

3.04%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

6.67%

ROE (avg)

5.51%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.05

EV to EBIT

25.79

EV to EBITDA

13.83

EV to Capital Employed

1.04

EV to Sales

1.42

PEG Ratio

Dividend Yield

ROCE (Latest)

4.03%

ROE (Latest)

1.44%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 105 Schemes (75.46%)

Foreign Institutions

Held by 177 Foreign Institutions (17.32%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 10.57% vs -5.51% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 46.67% vs 1,400.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "682.10",
          "val2": "616.90",
          "chgp": "10.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "80.60",
          "val2": "77.20",
          "chgp": "4.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.00",
          "val2": "9.30",
          "chgp": "-13.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.50",
          "val2": "-10.30",
          "chgp": "56.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "26.40",
          "val2": "18.00",
          "chgp": "46.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "74.50%",
          "val2": "79.90%",
          "chgp": "-0.54%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.18% vs -0.10% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1,016.37% vs -142.10% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,510.60",
          "val2": "2,566.50",
          "chgp": "-2.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "266.20",
          "val2": "487.50",
          "chgp": "-45.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "46.40",
          "val2": "63.40",
          "chgp": "-26.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,181.30",
          "val2": "-321.90",
          "chgp": "-266.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,118.60",
          "val2": "-100.20",
          "chgp": "-1,016.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "57.00%",
          "val2": "126.60%",
          "chgp": "-6.96%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

682.10

616.90

10.57%

Operating Profit (PBDIT) excl Other Income

80.60

77.20

4.40%

Interest

8.00

9.30

-13.98%

Exceptional Items

-4.50

-10.30

56.31%

Consolidate Net Profit

26.40

18.00

46.67%

Operating Profit Margin (Excl OI)

74.50%

79.90%

-0.54%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 10.57% vs -5.51% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 46.67% vs 1,400.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

2,510.60

2,566.50

-2.18%

Operating Profit (PBDIT) excl Other Income

266.20

487.50

-45.39%

Interest

46.40

63.40

-26.81%

Exceptional Items

-1,181.30

-321.90

-266.98%

Consolidate Net Profit

-1,118.60

-100.20

-1,016.37%

Operating Profit Margin (Excl OI)

57.00%

126.60%

-6.96%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -2.18% vs -0.10% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -1,016.37% vs -142.10% in Dec 2023

All Annual Results

Company CV

About Envista Holdings Corp.

Envista Holdings Corp.

Pharmaceuticals & Biotechnology

Envista Holdings Corporation is a dental products company. The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The Company operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Company Coordinates

Company Details

200 S Kraemer Blvd Bldg E , BREA CA : 92821-6208

Tel: 1 714 51677741 714 8177000

http://www.envistaco.com/

Registrar Details

Envista Holdings Corp.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Envista Holdings Corp.?

Watch in Real-Time

What does Envista Holdings Corp. do?

Who are in the management team of Envista Holdings Corp.?

Is Envista Holdings Corp. overvalued or undervalued?

Is Envista Holdings Corp. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Poor Management Efficiency with a low ROCE of 6.67%

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 5.77

Poor long term growth as Net Sales has grown by an annual rate of 2.21% over the last 5 years

Negative results in Jun 25

With ROCE of 4.03%, it has a risky valuation with a 1.04 Enterprise value to Capital Employed

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Envista Holdings Corp. Experiences Evaluation Revision Amidst Mixed Financial Metrics

Is Envista Holdings Corp. technically bullish or bearish?

Is Envista Holdings Corp. overvalued or undervalued?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About Envista Holdings Corp.

Company Coordinates